In addition, another preclinical study has shown that TGFβ played a role in the modulation of the response to RT, and that TGFβ blockade with RT enhanced dendritic cells activation and induced CD8+ T-cell responses to endogenous tumor antigens [50]. This evidence concerns the gene TGFB1 and neoplasm.